Deep Track Capital’s Century Therapeutics IPSC Stock Holding History

Deep Track Capital’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.4M	Buy	+9,487,745	New	+$19.9M	0.35%	52
2023 Q4	–	Sell	-543,008	Closed	-$1.09M	–	69
2023 Q3	$1.09M	Sell	543,008 -479,884	-47%	-$1.28M	0.04%	63
2023 Q2	$3.23M	Hold	1,022,892	–	–	0.15%	50
2023 Q1	$3.55M	Buy	1,022,892 +327,047	+47%	+$1.44M	0.15%	55
2022 Q4	$3.57M	Sell	695,845 -228,796	-25%	-$2.16M	0.15%	53
2022 Q3	$9.14M	Hold	924,641	–	–	0.42%	53
2022 Q2	$7.77M	Sell	924,641 -1,828	-0.2%	-$17.9K	0.51%	40
2022 Q1	$11.7M	Buy	926,469 +676,469	+271%	+$8.96M	0.75%	35
2021 Q4	$3.96M	Buy	+250,000	New	+$4.7M	0.28%	51

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deep Track Capital's IPSC Position: Q1 2026 in Review

Deep Track Capital opened a new position in Century Therapeutics (IPSC) in Q1 2026: 9,487,745 shares worth $21.4M. The stake represents 0.35% of the portfolio and ranks #52 among its holdings. This is a return to the name: Deep Track Capital previously reported a position in IPSC as recently as Q3 2023.

Deep Track Capital first reported a position in IPSC in Q4 2021 and has held it in 9 quarters since. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

Deep Track Capital held 9,487,745 shares of Century Therapeutics worth $21.4M as of Q1 2026.
Century Therapeutics was a new Deep Track Capital position in Q1 2026.
Century Therapeutics made up 0.35% of Deep Track Capital's portfolio in Q1 2026, its #52 holding.
Deep Track Capital first reported a position in Century Therapeutics in Q4 2021 and has held it in 9 quarters since.
72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Deep Track Capital's 13F filing for Q1 2026, filed 15 May 2026.